This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

U.S. District Court: Northern District of Georgia - Federal Trade Commission v. Watson Pharmaceuticals et al [order]

( February 22, 2010, 23:00 GMT | Official Statement) -- MLex Summary: U.S. District Court Judge Thomas W. Thrash, Jr. granted the defendants' motions to dismiss the Federal Trade Commission and indirect purchasers' pay-for-delay claims over the drug AndroGel. He ruled that the plaintiffs did not demonstrate that the settlement agreements exceeded the scope of the patent involved, or that the litigation involved was a sham. He also dismissed most of the direct purchasers' claims, but determined that the purchasers' allegations regarding the written description of the patent cannot be resolved at the pleading stage.Please see attached document...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections